For the assessment of intestinal permeability, size matters

Alternative Therapies in Health and Medicine

Volumn 19, Issue 1, 2013, Pages 12-24

  Vojdani, Aristo ^a,b  

^a Immunosciences Laboratories Inc   (United States)

^b Cyrex Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; IMMUNOGLOBULIN CLASS; LACTULOSE; MANNITOL;

AUTOIMMUNE DISEASE; DIFFUSION; HUMAN; INFLAMMATION; INTESTINE MUCOSA; MALABSORPTION; METABOLISM; MICROVILLUS; MOLECULAR WEIGHT; PARTICLE SIZE; PERMEABILITY; REVIEW; ULTRASTRUCTURE;

AUTOIMMUNE DISEASES; DIFFUSION; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFLAMMATION; INTESTINAL MUCOSA; LACTULOSE; MALABSORPTION SYNDROMES; MANNITOL; MICROVILLI; MOLECULAR WEIGHT; PARTICLE SIZE; PERMEABILITY;

MLCS; MLOWN;

EID: 84874425282     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Hober R. Ueber Resorption im Dünndarm Zweite Mittheilung. Pfluger's Arch. 1899,74: 246.
2. Hedon E. Compt Rend Soc Biol. 1900,52: 41-87.
3. Hewitt JA. The metabolism of carbohydrates, III: the absorption of glucose, fructose and galactose from the small intestine. Biochem J. 1924;18(1):161-170.
4. McCance RA, Madders K. The comparative rates of absorption of sugars from the human intestine. Biochem J. 1930;24(3):795-804.
5. Menzies IS. Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans. July 1974;2:1042-1047.
6. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroentesterol. 2002;34(4):385-396.
7. Vilela EG, Torres HO, Ferrari ML, Lima AS, Cunha AS. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41(12):1105-1109.
8. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Dig Dis. 1986;4(2):83-92.
9. Maxton DG, Bjarnason I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond). 1986;71(1):71-80.
10. Oman H, Akerblom E, Richter W, Johansson SG. Chemical and physiological properties of polysucrose, a new marker of intestinal permeability to macromolecules. Int Arch Allergy Immunol. 1992;98(3):220-226.
11. Oman H, Henriksson K, Blomqist L, et al. Increased intestinal permeability to a synthetic polysucrose in NSAID-treated patients. Eur J Gastroenterol Hepatol. 1992,4: 235-240.
12. Blomquist L, Oman H, Henriksson K, Johansson SGO. Increased absorption of polysucrose, a marker of intestinal paracellular permeability, in Crohn's disease. Eur J Gastroenterol Hepatol. 1993,5:913-917.
13. Bjarnason I, Zanelli G, Smith T, et al. Nonsteroidal anti-inflammatory druginduced intestinal inflammation in humans. Gastroenteroogyl. 1987;93(3):480-489.
14. Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984;2(8413):1171-1174.
15. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984;1(8370):179-182.
16. Peeters M, Hiele M, Ghoos Y, et al. Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardization. Gut. 1994;35(10):1404-1408.
17. Menzies IS, Zuckerman MJ, Nukajam WS, et al. Geography of intestinal permeability and absorption. Gut. 1994;44(4):483-489.
18. Li Q, Zhang Q, Wang M, et al. Interferon-gamma and tumor necrosis factoralpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol. 2008;126(1):67-80.
19. Oman H, Blomqist L, Henriksson AE, Johansson SG. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Scand J Gastroenterol. 1995;30(12):1172-1177.
20. Husby S, Foged N, Host A, Svehag SE. Passage of dietary antigens into the blood of children with celiac disease: quantification and size distribution of absorbed antigens. Gut. 1987;28(9):1062-1072.
21. Ménard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol. 2010;3(3):247-259.
22. Madara JL, Dharmsathaphorn K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J Cell Biol. 1985;101(6):2124-2133.
23. Weaver LT, Coombs RR. Does 'sugar' permeability reflect macromolecular absorption? A comparison of the gastro-intestinal uptake of lactulose and beta-lactoglobulin in the neonatal guinea pig. Int Arch Allergy Appl Immunol. 1988;85(1):133-135.
24. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011;141(5):769-776.
25. Jalonen T, Isolauri E, Heyman M, Crain-Denoyelle AM, Sillanaukee P, Koivula T. Increased beta-lactoglobulin absorption during rotavirus enteritis in infants: relationship to sugar permeability. Pediatr Res. 1991;30(3):290-293.
26. Gotteland M, Isolauri E, Heyman M, Tome D, Desjeux JF. Antigen absorption in bacterial diarrhea: in vivo intestinal transport of beta-lactoglobulin in rabbits infected with the entero-adherent Escherichia coli strain RDEC-1. Pediatr Res. 1989;26(3):237-240.
27. Klatt NR, Harris LD, Vinton CL, et al. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol. 2010;3(4):387-398.
28. Russell RG, Rosenkranz SL, Lee LA, et al. Epidemiology and etiology of diarrhea in colony-born Macaca nemestrina. Lab Anim Sci. 1987;37(3):309-316.
29. Hukkanen RR, Liggitt HD, Anderson DM, Kelley ST. Detection of systemic amyloidosis in the pig-tailed macaque (Macaca nemestrina). Comp Med. 2006;56(2):119-127.
30. Walker WA, Sanderson IR. Epithelial barrier function to antigens: an overview. Ann NY Acad Sci. 1992;664:10-17.
31. Paganelli R, Pallone F, Montano S, et al. Isotypic analysis of antibody response to a food antigen in inflammatory bowel disease. Int Arch Allergy Appl Immunol. 1985;78(1):81-85.
32. Eterman KP, Hekkens WT, Pena AS, Lems-van Kan PH, Feltkamp TE. Wheat grains; a substrate for the determination of gluten antibodies in serum of gluten-sensitive patients. J Immunol Methods. 1977;14(1):85-92.
33. Davidson IW, Lloyd RS, Whorwell PJ, Wright R. Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease. Clin Exp Immunol. 1979;35(1):147-148.
34. Juvonen P, Jakobssson I, Lindberg T. Macromolecular absorption and cows' milk allergy. Arch Dis Child. 1991;66(3):300-303.
35. Ford RP, Menzies IS, Philips AD, Walker-Smith JA, Turner MW. Intestinal sugar permeability: relationship to diarrhoeal disease and small bowel morphology. J Pediatr Gastroenterol Nutr. 1985;4(4):568-574.
36. Frick OL, German DF, Mills J. Development of allergy in children, I: association with virus infections. J Allergy Clin Immunol. 1979;63(4):228-241.
37. Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology. 1993;104(2):622-639.
38. Johansen FE, Pekna M, Nordenhaug IN, et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med. 1999;190(7):915-922.
39. Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. Gut. 1971;12(10):855-856.
40. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med. 2002;195(12):1653-1659.
41. Yoshida M, Claypool SM, Wagner JS, et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity. 2004;20(6):769-783.
42. Lamm ME. Current concepts in mucosal immunity, IV: how epithelial transport of IgA antibodies relates to host defense. Am J Physiol. 1998;274(4,pt 1):G614-G617.
43. Matysiak-Budnik T, Candalh C, Dugave C, et al. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology. 2003;125(3):696-707.
44. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med. 2008;205(1):143-154.
45. Schumann M, Richter JF, Wedell I, et al. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue. Gut. 2008;57(6):747-754.
46. Moura IC, Centelles MN, Arcos-Fajardo M, et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med. 2001;194(4):417-425.
47. Favre L, Spertini F, Corthesy B. Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol. 2005;175(5):2793-2800.
48. Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol. 2004;15(3):622-634.
49. Israel EJ, Taylor S, Wu Z, et al. Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology. 1997;92(1):69-74.
50. Shah U, Dickinson BL, Blumberg RS, Simister NE, Lencer WI, Walker WA. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res. 2003;53(2):295-301.
51. Kim JK, Tsen MF, Ghetie V, Ward ES. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur J Immunol. 1994;24(10):2429-2434.
52. Tesar DB, Tiangco NE, Bjorkman PJ. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic. 2006;7(9):1127-1142.
53. Caulfield MJ, Shaffer D. Immunoregulation by antigen/antibody complexes, I: specific immunosuppression induced in vivo with immune complexes formed in antibody excess. J Immunol. 1987;138(11):3680-3683.
54. Kaiserlian D, Lachaux A, Grosjean I, Graber P, Bonnefoy JY. Intestinal epithelial cells express the CD23/Fc epsilon RII molecule: enhanced expression in enteropathies. Immunology. 1993;80(1):90-95.
55. Negrao-Correa D, Adams LS, Bell RG. Intestinal transport and catabolism of IgE: a major blood-independent pathway of IgE dissemination during a Trichinella spiralis infection of rats. J Immunol. 1996;157(9):4037-4044.
56. Yang PC, Berin MC, Yu LC, Conrad DH, Perdue MH. Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (FcepsilonRII). J Clin Invest. 2000;106(7):879-886.
57. Zhou F, Kraehenbuhl JP, Neutra MR. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine. 1995;13(7):637-644.
58. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 2000;288(5474): 2222-2226.
59. Allan CH, Mendrick DL, Trier JS. Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterology. 1993;104(3):698-708.
60. Brandtzaeg P, Baekkevold ES, Farstad IN, et al. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today. 1999;20(3):141-151.
61. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr. 1999;69(5):1046S-1051S.
62. Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Noninvasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg. 2010;2(3):61-69.
63. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151-175.
64. Forsyth CB, Shannon KM, Kordower JH, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS ONE. 2011;6(12): e28032.
65. Mahdi H, Fisher BA, Källberg H, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat Genet. 2009;41(12):1319-1324.
66. Inoue H, Mishima K, Yamamoto-Yoshida S, et al. Aryl hydrocarbon receptermediated induction of EBV reactivation as a risk factor for Sjögren's syndrome. J Immunol. 2012;188(9):4654-4662.
67. Pollard KM. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun. 2012;38(2-3):J177-J186.
68. Sapone A, de Magistris L, Pietzak M, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55(5):1443-1449.
69. Blanas E, Carbone FR, Allison J, Miller JF, Heath WR. Induction of autoimmune di abetes by oral admi nistrati on of autoanti gen. Science. 1996;274(5293):1707-1709.
70. Sabbah E, Savola K, Ebeling T, et al. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care. 2000;23(9):1326-1332.
71. Persaud DR, Baranco-Mendoza A. Bovine serum albumin and insulin-dependent diabetes mellitus: is cow's milk still a possible toxicological causative agent of diabetes? Food Chem Toxicol. 2001;42(5):707-714.
72. Vojdani A, Pangborn JB, Vojdani E, Cooper EL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003;16(3):189-199.
73. Vaarala O. The gut immune system and type 1 diabetes. Ann NY Acad Sci. Apr 2002;958:39-46.
74. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34(4):385-396.
75. Carratu R, Secondulfo M, de Magistris L, et al. Altered intestinal permeability to mannitol in diabetes mellitus type 1. J Pediatr Gastroenterol Nutr. 1999;28(3):264-269.
76. De Magistris L, Secondulfo M, Sapone A, et al. Infection with Giardia and intestinal permeability in humans. Gastroenterology. 2003;125(1):277-279.
77. nd ed. Boca Raton, FL: CRC Press; 2001:697-722.
78. Secondulfo M, Iafusco D, Carratu R, et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type 1 diabetic patients. Dig Liver Dis. 2004;36(1):35-45.
79. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):416-422.
80. Yacyshyn B, Meddings J, Sadowski D, Bowen-Yacyshyn MB. Multiple sclerosis patients have peripheral blood CD45RO+ B cells an increased intestinal permeability. Dig Dis Sci. 1996;41(12):2493-2498.
81. Meddings JB, Jarand J, Urbanski SJ, Hardin J, Gall DG. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol. 1999;276(4, pt 1):G951-G957.
82. Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type 1 diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA. 2005;102(8):2916-2921.
83. Ellenberg M. Nonneurologic manifestations of diabetic neuropathy. Mt Sinai J Med. 1980;47(6):561-567.
84. Correale J, Villa A. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity. 2007;40(2):148-160.
85. Morgan L, Shah B, Rivers LE, et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience. 2007;147(3):664-673.
86. Lebouvier T, Chaumette T, Paillusson S, et al. The second brain and Parkinson's disease. Eur J Neurosci. 2009;30(5):735-741.
87. Dorsey ER, Constantinescu R, Thonpson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384-386.
88. Savidge TC, Sofroniew MV, Neunlist M. Starring roles for astroglia in barrier pathologies of gut and brain. Lab Invest. 2007;87(8):731-736.
89. Shults CW. Lewy bodies. Proc Natl Acad Sci USA. 2006;103(6):1661-1668.
90. Braak H, Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology. 2008;70(20):1916-1925.
91. Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neurol Transm. 2003;110(5):517-536.
92. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599-614.
93. Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL. Alphasynuclerin-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience. 2008;153(3):733-750.
94. Qin L, Wu X, Block ML, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453-462.
95. Wang S, Yan JY, Lo YK, Carvey PM, Ling Z. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacteria lipopilysaccharide. Brain Res. Apr 2009;1265:196-204.
96. Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol. 2007;150(8):963-976.
97. Murakami M, Ohta T, Ito S. Lipopolysaccharides enhance the action of bradykinin in enteric neurons via secretion of interleukin-1beta from enteric glial cells. J Neurosci Res. 2009;87(9):2095-2104.
98. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008;29(1):117-124.
99. Neutra MR, Kraehenbuhl JP. Cellular and molecular basis for antigen trans-port across epithelial barriers. In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L, eds. Mucosal Immunol. Vol 1. 3rd ed. Burlington, MA: Elsevier Academic Press; 2005:111-130.